185 related articles for article (PubMed ID: 19346125)
1. Epigenetic therapies in haematological malignancies: searching for true targets.
Altucci L; Minucci S
Eur J Cancer; 2009 May; 45(7):1137-1145. PubMed ID: 19346125
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic modulation in hematologic malignancies: challenges and progress.
Mitsiades CS; Anderson KC
J Natl Compr Canc Netw; 2009 Nov; 7 Suppl 8():S1-12; quiz S14-6. PubMed ID: 19930971
[TBL] [Abstract][Full Text] [Related]
5. The use of hypomethylating agents in the treatment of hematologic malignancies.
Kihslinger JE; Godley LA
Leuk Lymphoma; 2007 Sep; 48(9):1676-95. PubMed ID: 17786703
[TBL] [Abstract][Full Text] [Related]
6. [Epigenetic therapy for hematologic malignancies].
Kobayashi Y
Rinsho Ketsueki; 2015 Oct; 56(10):2015-23. PubMed ID: 26458440
[TBL] [Abstract][Full Text] [Related]
7. DNA demethylating agents and histone deacetylase inhibitors in hematologic malignancies.
Fandy TE; Carraway H; Gore SD
Cancer J; 2007; 13(1):40-8. PubMed ID: 17464245
[TBL] [Abstract][Full Text] [Related]
8. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
9. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
Valdespino-Gómez VM; Valdespino-Castillo VE
Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
[TBL] [Abstract][Full Text] [Related]
10. The future of epigenetic therapy in solid tumours--lessons from the past.
Azad N; Zahnow CA; Rudin CM; Baylin SB
Nat Rev Clin Oncol; 2013 May; 10(5):256-66. PubMed ID: 23546521
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias.
Leone G; Teofili L; Voso MT; Lübbert M
Haematologica; 2002 Dec; 87(12):1324-41. PubMed ID: 12495905
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylases and epigenetic therapies of hematological malignancies.
Mercurio C; Minucci S; Pelicci PG
Pharmacol Res; 2010 Jul; 62(1):18-34. PubMed ID: 20219679
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.
Lu Y; Chan YT; Tan HY; Li S; Wang N; Feng Y
Mol Cancer; 2020 Apr; 19(1):79. PubMed ID: 32340605
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics in the hematologic malignancies.
Fong CY; Morison J; Dawson MA
Haematologica; 2014 Dec; 99(12):1772-83. PubMed ID: 25472952
[TBL] [Abstract][Full Text] [Related]
15. DNA demethylating agents and epigenetic therapy of cancer.
Mani S; Herceg Z
Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
Oh S; Ko JY; Oh C; Yoo KH
Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic therapy in hematological cancers.
Dimopoulos K; Grønbaek K
APMIS; 2019 May; 127(5):316-328. PubMed ID: 30859683
[TBL] [Abstract][Full Text] [Related]
18. Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy.
Rondelet G; Wouters J
Biochimie; 2017 Aug; 139():137-147. PubMed ID: 28600135
[TBL] [Abstract][Full Text] [Related]
19. [A primer for epigenetics of hematological malignancies].
Nakajima H
Rinsho Ketsueki; 2016; 57(10):1835-1844. PubMed ID: 27725578
[TBL] [Abstract][Full Text] [Related]
20. Demethylation of DNA by decitabine in cancer chemotherapy.
Brown R; Plumb JA
Expert Rev Anticancer Ther; 2004 Aug; 4(4):501-10. PubMed ID: 15270655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]